Medical device company Viacyte has developed a device called\u00a0PEC-Direct that can protect stem cells to be able to live inside the body, produce insulin as needed and possibly cure type 1 diabetes (T1D).\r\n\r\nStem cells are placed into PEC-Direct and take three months to become functioning islet cells. Viacyte recently implanted the device into two patients with type 1 diabetes. Paul Laikind of Viacyte said if it works, we will call it a functional cure due to the fact that it doesn't address the autoimmune cause of the disease.\r\n\r\nI always get excited when I read about stem cells curing diabetes, or any disease for that matter. The only drawback is that patients would still need to take steroids or other\u00a0immunosuppression drugs. I would take that trade off for now. Hopeful the scientists will discover a way to use PEC-Direct without immunosuppression.\r\n\r\n\r\n\r\nRead the full article here!